Clozapine plus lamotrigine in treatment-resistant schizophrenia.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Archives of General Psychiatry

• Publication date

  1999-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHPSYC.56.10.950PMID 10530638
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk factors for binge eating disorder: a community-based, case-control study.

  1998cited by this paper
• Evaluation of treatment-resistant schizophrenia.

  1997cited by this paper
• Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia

  1989cited by this paper

• Schizophrenia and Related Psychoses

  2021cites this paper
• Bidirectional Modulation of the Voltage-Gated Sodium (Nav1.6) Channel by Rationally Designed Peptidomimetics

  2020cites this paper
• The integrated model of glutamate and dopamine hypothesis for schizophrenia: Prediction and personalized medicine for prevent potential treatment-resistant patients.

  2020cites this paper
• Glutamate modulators for treatment of schizophrenia

  2019cites this paper
• Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics

  2018cites this paper
• Schizophrenia Aetiology and Drug Therapy: A Tale of Progressive Demystification and Strides in Management

  2018cites this paper
• Current trends in the use of anticonvulsants in psychiatric practice

  2017cites this paper
• The use of adjuvant L-arginine in schizophrenia: A behavioural and neurochemical analysis

  2016cites this paper
• Instructions for use Title Lamotrigine blocks repeated high-dose methamphetamine- induced behavioral sensitization to dizocilpine (MK-801), but not methamphetamine in rats

  2016cites this paper
• Rapid-onset agranulocytosis in a patient treated with clozapine and lamotrigine.

  2015cites this paper
• Risk Level Classification Dementia or Determination of Dementia via Chaos Technique

  2015cites this paper
• Glutamate and dopamine in schizophrenia: An update for the 21st century

  2015cites this paper
• The contribution of the brain response to ketamine to understanding the glutamatergic system and its role in human cognition

  2013cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

  2012cites this paper
• The Psychopharmacology of Aggressive Behavior: A Translational Approach Part 1 Neurobiology

  2012cites this paper
• The Psychopharmacology of Aggressive Behavior: A Translational Approach Part 2 Clinical Studies Using Atypical Antipsychotics, Anticonvulsants, and Lithium

  2012cites this paper
• Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine.

  2011cites this paper
• The Efficacy of Sodium Channel Blockers to Prevent Phencyclidine-Induced Cognitive Dysfunction in the Rat: Potential for Novel Treatments for Schizophrenia

  2011cites this paper
• Lamotrigine blocks repeated high-dose methamphetamine-induced behavioral sensitization to dizocilpine (MK-801), but not methamphetamine in rats.

  2011cites this paper
• Clozapine-related EEG changes and seizures: dose and plasma-level relationships

  2011cites this paper
• Effects of lamotrigine on PCP-evoked elevations in monoamine levels in the medial prefrontal cortex of freely moving rats

  2011cites this paper
• Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

  2011cites this paper
• Research in people with psychosis risk syndrome: a review of the current evidence and future directions.

  2010cites this paper
• Augmenting Clozapine Response in Treatment-Resistant Schizophrenia

  2010cites this paper
• Estrategias farmacológicas de potenciación en esquizofrenia refractaria a clozapina: más alla de la resistencia

  2010cites this paper
• The psychotomimetic effects of PCP , LSD and MDMA : Pharmacological models of schizophrenia ?

  2009cites this paper
• [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].

  2009cites this paper
• Current perspectives in the treatment of resistant schizophrenia

  2009cites this paper
• Review: lamotrigine may be an effective treatment for clozapine resistant schizophrenia

  2009cites this paper
• Enquête observationnelle de prescription de la clozapine au centre hospitalier Charles-Perrens à Bordeaux, plus de 15 ans après l’AMM en France

  2009cites this paper
• A Double-Blind Randomized Trial of Mood Stabilizer Augmentation Using Lamotrigine and Valproate for Patients With Schizophrenia Who Are Stabilized and Partially Responsive

  2009cites this paper
• Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence?

  2009cites this paper
• The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis.

  2009cites this paper
• Psikiyatrik bozukluklarda lamotrijin kullanımı

  2008cites this paper
• Antiepileptics in the Treatment of Schizophrenia

  2008cites this paper
• Off-label prescribing of anticonvulsant drugs

  2008cites this paper
• Clozapine Versus “High-Dose” Olanzapine in Refractory Early-Onset Schizophrenia: An Open-Label Extension Study

  2008cites this paper
• Atypical Antipsychotics: CATIE Study, Drug-Induced Movement Disorder and Resulting Iatrogenic Psychiatric-Like Symptoms, Supersensitivity Rebound Psychosis and Withdrawal Discontinuation Syndromes

  2008cites this paper
• Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.

  2007cites this paper
• The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study.

  2007influential citation
• Lamotrigine as Add-On Therapy in Schizophrenia: Results of 2 Placebo-Controlled Trials

  2007cites this paper
• Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?

  2007cites this paper
• Neuroprotective agents in schizophrenia and affective disorders

  2006cites this paper
• Non-epilepsy uses of antiepileptic drugs

  2006cites this paper
• Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients

  2006cites this paper
• Medication options for treatment-resistant schizophrenia: implications for global mental health financing

  2006cites this paper
• Treatment-refractory schizophrenia in children and adolescents: an update on clozapine and other pharmacologic interventions.

  2006cites this paper
• Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivity.

  2006cites this paper
• Non-epilepsy uses of antiepilepsy drugs.

  2006cites this paper
• Dealing with treatment resistance to clozapine : characteristics of treatment response in schizophrenia

  2006cites this paper
• Efeitos da estimulação magnética transcraniana de repetição nas alucinações auditivas de pacientes com esquizofrenia super-refratária ao tratamento

  2006cites this paper
• Adjunctive lamotrigine in treatment-resistant schizophrenia.

  2005cites this paper
• Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania.

  2005cites this paper
• Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia

  2005cites this paper
• Augmentation Strategies in Clozapine-Resistant Schizophrenia

  2005cites this paper
• Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?

  2005cites this paper
• A survey of the off-label use of mood stabilizers in a large psychiatric hospital

  2005cites this paper
• Randomized controlled augmentation trials in clozapine-resistant schizophrenic patients: a critical review

  2005cites this paper
• Does the addition of lamotrigine to risperidone improve psychotic symptoms and cognitive impairments in chronic schizophrenia

  2005cites this paper
• Addition of lamotrigine to clozapine in inpatients with chronic psychosis.

  2005cites this paper
• Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat

  2005cites this paper
• Lamotrigine in the treatment of bipolar disorder

  2005cites this paper
• Increase in risperidone plasma level with lamotrigine.

  2005cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia

  2005cites this paper
• Worsening of psychotic symptoms in schizophrenia with addition of lamotrigine: a case report.

  2005cites this paper
• The potential role of lamotrigine in schizophrenia

  2005cites this paper
• High Frequency of Bipolar Spectrum in Outpatients with Depression

  2004cites this paper
• Lamotrigine for bipolar disorder: translating research into clinical practice

  2004cites this paper
• Placebo-Controlled Trial of Lamotrigine Added to Conventional and Atypical Antipsychotics in

  2004cites this paper
• Long-Term Lamotrigine Adjunctive to Antipsychotic Monotherapy in Schizophrenia: Further Evidence

  2004cites this paper
• A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation.

  2004cites this paper
• Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia.

  2004cites this paper
• Glutamate as a therapeutic target in psychiatric disorders

  2004cites this paper
• Successful Antimanic Treatment and Mood Stabilization with Lamotrigine, Clozapine, and Valproate in a Bipolar Patient after Lithium-induced Cerebellar Deterioration

  2003cites this paper
• NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

  2003cites this paper
• Medicamentos antiepilépticos en la esquizofrenia: una revisión

  2003cites this paper
• Effect of Riluzole on MK-801 and Amphetamine-Induced Hyperlocomotion

  2003cites this paper
• Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial.

  2003cites this paper
• New uses for lithium and anticonvulsants.

  2003cites this paper
• Serum Clozapine Levels: A Review of Their Clinical Utility

  2003cites this paper
• Ziprasidone Induction of Hypomania in Depression ?

  2002influential citation
• Klozapin Tedavisini Güçlendirme: Bir Gözden Geçirme

  2002cites this paper
• Clozapine-resistant schizophrenia: A positive approach

  2002cites this paper
• Antischizophrenic activity independent of dopamine D2 blockade

  2002cites this paper
• Lamotrigine--clozapine combination in refractory schizophrenia: three cases.

  2002cites this paper
• Antiepileptic drugs in schizophrenia: a review

  2002cites this paper
• Epilepsy, psychosis and clozapine

  2002cites this paper
• Topiramate for refractory schizophrenia.

  2002cites this paper
• Lamotrigine reduces spontaneous and evoked GABAA receptor-mediated synaptic transmission in the basolateral amygdala: implications for its effects in seizure and affective disorders.

  2002cites this paper
• TREATMENT STRATEGIES: MEDICATION Antipsychotics

  2002cites this paper
• Allopurinol augmentation for poorly responsive schizophrenia.

  2001cites this paper
• Lack of phencyclidine-induced effects in mice with reduced neuronal nitric oxide synthase

  2001cites this paper
• Antipsychotic drug treatment: recent advances

  2001cites this paper
• Elevated clozapine plasma level with lamotrigine.

  2001cites this paper
• Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic caseseries outcome study

  2001cites this paper
• Management of treatment resistance in schizophrenia.

  2001cites this paper
• Treatment of the special patient with schizophrenia

  2001cites this paper
• When symptoms persist: clozapine augmentation strategies.

  2001cites this paper
• Association between premenstrual syndrome and depression.

  2000cites this paper
• Augmentation with sulpiride for a schizophrenic patient partially responsiveto clozapine

  2000cites this paper